Skip to main content
. 2020 Oct 29;12(10):e11244. doi: 10.7759/cureus.11244

Table 3. Variables and their association with Neisseria gonorrhoeae in men.

dL: deciliter; ED: Emergency department; EMS: Emergency medical services; HPF: High-power field; mg: milligram; NA: Not applicable; OR: Odds ratio; PCP: Primary care physician; SD: Standard deviation; STD: Sexually transmitted disease; STI: Sexually transmitted infection; UTI: Urinary tract infection; vs: versus; WBC: White blood cell; y: year.

Adjusting for age, race, and emergency severity index score. ORs for continuous variables are stated as per unit change in regressor.

  + N gonorrhoeae − N gonorrhoeae P Value Adjusted OR (95% CI) Adjusted P Value
Age, mean (SD), y 26.4 (7.2) (n = 418) 31.5 (11.2) (n = 2,703) < .001 .94 (.93-.96) < .001
Black race (vs not Black) 93.0% (387/416) 86.1% (2,312/2,685) < .001 1.90 (1.26-2.85) .002
Married/life partner (vs not married) 4.6% (19,418) 9.3% (249/2,687) .001 .96 (.58-1.59) .86
Emergency severity index score, mean (SD), level 1-5 3.8 (.5) (n = 392) 3.6 (.6) (n = 2,558) < .001 1.46 (1.21-1.77) < .001
Having a (PCP) (vs none) 17.5% (73/418) 18.7% (505/2,703) .59 .91 (.69-1.22) .54
Arrived to ED by EMS/police (vs other) 1.5% (6/412) 3.8% (103/2,681) .01 .46 (.18-1.17) .10
ED triage pain scale, mean (SD) (0-10) 2.4 (3.5) (n = 27) 3.5 (3.8) (n = 231) .17 .77 (.47-1.26) .30
Mentioned “STD,” “STI,” “sexually transmitted,” “penis,” or “discharge” at ED point of contact (vs not) 65.6% (274/418) 44.4% (1,201/2,703) < .001 1.77 (1.39-2.25) < .001
Mentioned “UTI,” “bladder infection” or “pain,” “urinary tract infection,” “cystitis,” “dysuria,” “frequency” or “frequent urination,” or “urgency” at ED point of contact (vs not) 4.8% (20/418) 4.6% (125/2,703) .90 1.59 (.95-2.66) .07
Mentioned “abdominal pain,” “abdominal discomfort,” or “abdominal cramping” at ED point of contact (vs not) 4.1% (17/418) 6.0% (163/2,703) .12 .93 (.55-1.58) .80
Diagnosed in the ED with a urinary tract infection (vs not) 8.6% (36/418) 4.2% (113/2,703) < .001 2.87 (1.88-4.39) < .001
Treated with metronidazole in the ED or given it as an outpatient prescription (vs not) 44.5% (186/418) 28.9% (780/2,703) < .001 1.63 (1.30-2.05) < .001
Treated for gonorrhea and chlamydia (vs not) 90.7% (379/418) 57.6% (1,558/2,703) < .001 6.40 (4.46-9.19) < .001
Infected with N gonorrhoeae (vs not) 3.9% (5/127) 9.5% (63/662) .04 .32 (.10-1.06) .06
Infected with T vaginalis (vs not) 27.3% (114/418) 12.6% (341/2,701) < .001 1.94 (1.49-2.51) < .001
Urinalysis          
WBC count (cells/HPF), mean (SD) 72.3 (36.3) (n = 192) 23.2 (31.3) (n = 846) < .001 1.03 (1.03-1.04) < .001
WBC clumps present (vs not) 18.0% (34/189) 6.7% (56/839) < .001 3.65 (2.16-6.16) < .001
Mucus (0, 1+, 2+, 3+, or 4+), mean (SD) 1.2 (1.4) (n = 192) 1.2 (1.4) (n = 846) .49 .87 (.77-.99) .04
Leukocyte esterase (0, 1+, 2+, or 3+), mean (SD) 2.1 (1.1) (n = 204) 0.4 (.8) (n = 1,628) < .001 3.99 (3.39-4.70) < .001
Bacteria (0, 1+, 2+, 3+, or 4+), mean (SD) 0.6 (.8) (n = 192) 0.6 (.9) (n = 845) .51 1.07 (.87-1.31) .53
Nitrite positive (vs negative) 1.9% (4/208) 1.8% (30/1,641) .79 2.86 (.92-8.89) .07
Blood (0, 1+, 2+, or 3+), mean (SD) .4 (.6) (n = 205) .3 (.8) (n = 1,625) .66 1.28 (1.04-1.56) .02
Red blood cells (cells/HPF), mean (SD) 10.2 (17.5) (n = 189) 11.8 (25.1) (n = 846) .30 1.00 (.99-1.01) .91
Squamous epithelial cells (cells/HPF), mean (SD) .1 (0.4) (n = 36) 1.3 (2.9) (n = 238) < .001 .33 (.12-.91) .03
pH (5-9), mean (SD) 6.1 (.9) (n = 208) 6.0 (.9) (n = 1,642) .19 1.02 (.86-1.21) .81
Bilirubin (0, 1+, 2+, or 3+), mean (SD) .1 (.5) (n = 208) .05 (.3) (n = 1,637) .09 1.46 (1.02-2.08) .04
Urobilinogen (0, 2, 4, 8, or 12 mg/dL), mean (SD) 1.2 (1.9) (n = 208) .8 (1.5) (n = 1,641) .002 1.09 (1.00-1.18) .06
Protein (0, .5+, 1+, 2+, 3+), mean (SD) .42 (.6) (n = 208) .31 (.6) (n = 1,641) .02 1.42 (1.13-1.79) .003
Glucose present (vs not) 2.9% (6/208) 4.8% (78/1,639) .29 .83 (.32-2.19) .71
Ketones (0, .5+, 1+, 2+, 3+), mean (SD) .1 (.3) (n = 208) .1 (.4) (n = 1,639) .16 .83 (.52-1.32) .43